Fundraising FoxOmios Biologics
1 known investors
Find your way into Omios Biologics
Omios Biologics runs a computational drug discovery platform that analyzes viral-host interactions across more than 270 human viruses to identify disease targets and engineer precision therapeutics. Its lead assets are biomarker-driven engineered oncolytic viruses for specific cancer subtypes, with expansion into immune, inflammatory, metabolic, and neurodegenerative diseases.
Investors · 1
Frequently asked questions
- What does Omios Biologics do?
- Omios Biologics runs a computational drug discovery platform that analyzes viral-host interactions across more than 270 human viruses to identify disease targets and engineer precision therapeutics. Its lead assets are biomarker-driven engineered oncolytic viruses for specific cancer subtypes, with expansion into immune, inflammatory, metabolic, and neurodegenerative diseases.
- Who are Omios Biologics's investors?
- Omios Biologics's investors include NYU Innovation Venture Fund.